A BILL 
To amend the Public Health Service Act to provide for 
a national system for surveillance of vaccine rates, to 
authorize research on vaccine hesitancy, to increase pub-
lic understanding of the benefits of immunizations, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Vaccine Awareness 
4
Campaign to Champion Immunization Nationally and En-
5
hance Safety Act of 2019’’ or the ‘‘VACCINES Act of 
6
2019’’. 
7
03:03 Jun 05, 2019
H2862
2 
•HR 2862 IH
SEC. 2. VACCINE SURVEILLANCE AND RESEARCH. 
1
(a) IN GENERAL.—Section 317 of the Public Health 
2
Service Act (42 U.S.C. 247b) is amended by adding at 
3
the end the following new subsection: 
4
‘‘(n) VACCINE SURVEILLANCE AND RESEARCH.— 
5
‘‘(1) SURVEILLANCE.— 
6
‘‘(A) IN GENERAL.—The Secretary, acting 
7
through the Director of the Centers for Disease 
8
Control and Prevention, and in consultation 
9
with the National Vaccine Advisory Committee 
10
and the Director of the National Vaccine Pro-
11
gram, shall develop and deploy a national sys-
12
tem for surveillance of vaccination rates. 
13
‘‘(B) AUTHORIZED ACTIVITIES.—The sur-
14
veillance system under subparagraph (A) may 
15
include the following: 
16
‘‘(i) Use of immunization data avail-
17
able to the Centers for Disease Control 
18
and Prevention and its contractors. 
19
‘‘(ii) Integration of data from existing 
20
systems— 
21
‘‘(I) to measure vaccination con-
22
fidence over time; 
23
‘‘(II) to understand variations 
24
across time and geography; and 
25
‘‘(III) to measure vaccine refusal. 
26
03:03 Jun 05, 2019
H2862
3 
•HR 2862 IH
‘‘(C) USE OF DATA.—The Secretary may 
1
use data collected pursuant to the surveillance 
2
system under subparagraph (A) to predict and 
3
identify areas and communities where— 
4
‘‘(i) vaccines are or will be underuti-
5
lized; 
6
‘‘(ii) vaccine confidence is low or de-
7
creasing; or 
8
‘‘(iii) misinformation about the safety 
9
of vaccines, not supported by scientific or 
10
medical evidence, has been directed in a 
11
targeted manner. 
12
‘‘(D) CONSULTATION.—In developing the 
13
surveillance system under subparagraph (A), 
14
the Secretary shall consult with the National 
15
Academies to synthesize existing evidence and 
16
develop a standardized measurement of vaccine 
17
confidence. 
18
‘‘(E) FUNDING.—There are authorized to 
19
be appropriated $15,000,000 for each of fiscal 
20
years 2020 through 2024 to carry out this 
21
paragraph. 
22
‘‘(2) GRANTS FOR RESEARCH.—The Secretary 
23
may award grants for research— 
24
03:03 Jun 05, 2019
H2862
4 
•HR 2862 IH
‘‘(A) to improve the understanding of vac-
1
cine hesitancy; 
2
‘‘(B) to improve understanding of health 
3
care provider attitudes and beliefs toward vac-
4
cination; and 
5
‘‘(C) to develop effective strategies for ad-
6
dressing non-adherence to the safe and rec-
7
ommended use of vaccines and encouraging the 
8
safe and recommended use of vaccines.’’. 
9
(b) UPDATE OF 2015 NVAC REPORT.—The National 
10
Vaccine Advisory Committee shall— 
11
(1) assess the state of vaccine confidence in the 
12
United States; and 
13
(2) update the findings and recommendations in 
14
the report on this topic approved by the National 
15
Vaccine Advisory Committee on June 10, 2015. 
16
SEC. 3. PUBLIC AWARENESS CAMPAIGN ON THE IMPOR-
17
TANCE OF VACCINATIONS. 
18
Section 317 of the Public Health Service Act (42 
19
U.S.C. 247b), as amended by section 3, is further amend-
20
ed by adding at the end the following new subsection: 
21
‘‘(o) PUBLIC AWARENESS CAMPAIGN ON THE IMPOR-
22
TANCE OF VACCINATIONS.— 
23
‘‘(1) IN
GENERAL.—The Secretary, acting 
24
through the Director of the Centers for Disease 
25
03:03 Jun 05, 2019
H2862
5 
•HR 2862 IH
Control and Prevention, shall carry out a national 
1
campaign to increase awareness of the importance 
2
of, combat misinformation about, and increase rates 
3
of, vaccinations across the lifespan. 
4
‘‘(2) CONSULTATION.—In carrying out the cam-
5
paign under this subsection, the Secretary shall con-
6
sult with the National Academy of Medicine and na-
7
tionally recognized private entities, including medical 
8
and public health associations and nonprofit organi-
9
zations, to solicit advice on evidence-based informa-
10
tion for policy development and program develop-
11
ment, implementation, and evaluation. 
12
‘‘(3) REQUIREMENTS.—The campaign under 
13
this subsection— 
14
‘‘(A) shall be an evidence-based media and 
15
public engagement initiative; 
16
‘‘(B) shall be carried out through competi-
17
tively bid contracts awarded to one or more 
18
public or private entities; 
19
‘‘(C) may include the use of television, 
20
radio, print, the internet, and other commercial 
21
marketing venues; 
22
‘‘(D) may include the use of in-person pub-
23
lic communications; 
24
‘‘(E) may be targeted to— 
25
03:03 Jun 05, 2019
H2862
6 
•HR 2862 IH
‘‘(i) specific groups and local needs of 
1
communities with high rates of unvaccinat-
2
ed individuals; or 
3
‘‘(ii) areas or communities identified 
4
pursuant to subsection (n)(1)(C); 
5
‘‘(F) shall include the development of cul-
6
turally and linguistically competent resources 
7
that may be tailored for communities with high 
8
rates of unvaccinated individuals; 
9
‘‘(G) shall include the dissemination of 
10
vaccine information and vaccine communication 
11
resources to health care providers and health 
12
care facilities, including pharmacists, State and 
13
local public health departments, and health care 
14
providers and facilities that provide prenatal 
15
and pediatric care; 
16
‘‘(H) may include the use of recognized 
17
trusted figures; 
18
‘‘(I) shall be complementary to, and coordi-
19
nated with, any other Federal efforts; 
20
‘‘(J) shall include message testing to iden-
21
tify culturally competent and effective messages 
22
for behavioral change; 
23
‘‘(K) may include the dissemination of in-
24
formation highlighting— 
25
03:03 Jun 05, 2019
H2862
7 
•HR 2862 IH
‘‘(i) advancements in research and 
1
vaccine development that have saved mil-
2
lions of individuals from death and dis-
3
ability from now-preventable diseases; 
4
‘‘(ii) information on how individuals 
5
across the lifespan benefit from immuniza-
6
tions, including those who cannot be vac-
7
cinated and rely on community immunity; 
8
‘‘(iii) information on the dangers of 
9
not being vaccinated, including the poten-
10
tial for infectious disease outbreaks within 
11
communities; and 
12
‘‘(iv) information on vaccine safety 
13
and the systems in place to monitor vac-
14
cine safety; 
15
‘‘(L) shall include the award of grants to 
16
State, local, and tribal public health depart-
17
ments— 
18
‘‘(i) to identify and prioritize engage-
19
ment with communities with high rates of 
20
unvaccinated individuals; 
21
‘‘(ii) to engage communities with high 
22
rates of unvaccinated individuals in under-
23
standing the challenges to increasing vac-
24
cination rates in the respective commu-
25
03:03 Jun 05, 2019
H2862
8 
•HR 2862 IH
nities and developing effective strategies 
1
(including through formative research or 
2
focus groups) to increase such rates; and 
3
‘‘(iii) to encourage partnerships with 
4
community organizations and health care 
5
providers to develop and deliver evidence 
6
based interventions to increase vaccination 
7
rates; and 
8
‘‘(M) may include the development and dis-
9
semination of evidence-based scientific curricula 
10
for use in public elementary schools and sec-
11
ondary schools (as defined in section 8101 of 
12
the Elementary and Secondary Education Act 
13
of 1965) on infectious disease outbreaks and 
14
how they can be prevented and controlled. 
15
‘‘(4) EVALUATION.—The Secretary shall— 
16
‘‘(A) establish baseline measures and 
17
benchmarks to quantitatively evaluate the im-
18
pact of the campaign under this subsection; 
19
‘‘(B) conduct qualitative assessments re-
20
garding the effectiveness of strategies employed 
21
under this subsection; and 
22
‘‘(C) prepare and submit to the Committee 
23
on Energy and Commerce of the House of Rep-
24
resentatives and the Committee on Health, 
25
03:03 Jun 05, 2019
H2862
9 
•HR 2862 IH
Education, Labor, and Pensions of the Senate 
1
an evaluation of the campaign. 
2
‘‘(5) FUNDING.—There are authorized to be ap-
3
propriated $6,000,000 for each of fiscal years 2020 
4
through 2024 to carry out this subsection.’’. 
5
Æ 
03:03 Jun 05, 2019
H2862
